Friday, 20 Apr 2018

You are here

Dr. Janet Pope: JAK 2 Inhibitor Controversy

Dr. Janet Pope talks about JAK 2 inhibitors and increased VTE as presented at the ACR/ARHP Annual Meeting in San Diego.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
ACR VIDEO

Dr. Olga Petryna - Ustekinumab in...

24 Jul 2017

RWCS 2017: Interpreting Skin Biopsies...

10 Apr 2017

Dr. Philip Robinson: Osteoarthritis and...

08 Nov 2017

Jack Cush, MD: Safety Perspective on...

13 Nov 2015

Dr. Len Calabrese: New IL-6 therapies,...

14 Nov 2016

The RheumNow Week in Review – 6 January...

06 Jan 2017

Dr. Jack Cush and Dr. Pete Salzmann (...

07 Nov 2017

Daniel Lovell, MD: abatacept in JIA

11 Nov 2015

The RheumNow Week in Review – 3...

03 Feb 2017

Dr. Orrin Troum and Dr. Alvin Wells: OA...

09 Feb 2018

RheumNow Week in Review – 16 December...

16 Dec 2016

Dr. Olga Petryna: FRAME Study

05 Nov 2017